UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Ministry revokes Kolon Life Science’s innovative drug company status
by Lee Han-soo
2019-11-15 17:26
AbbVie presents new data for ankylosing spondylitis treatment in US
by Lee Han-soo
2019-11-15 11:40
Merck Korea wins award for helping families with infertility problems
by Lee Han-soo
2019-11-14 18:05
Prosecutors raid drugmakers, distributors for suspected bid-rigging
by Jeong Sae-im
2019-11-14 15:27
‘Novartis’ Kymriah takes one step closer to cancer cure’
by Lee Han-soo
2019-11-14 13:24
라인
iCure to apply for testing incrementally modified cancer drugs in US
by Lee Han-soo
2019-11-13 17:35
JW Pharmaceutical launches joint-stock company in Vietnam
by Lee Han-soo
2019-11-13 16:52
‘Generic drugs must indicate ingredient names on label’
by Kim Yun-mi
2019-11-13 15:51
Daewoong releases trial results for autoimmune disease treatment in US
by Lee Han-soo
2019-11-12 14:09
Hanmi to get ₩11.6 billion in royalty if FDA approves Rolontis
by Lee Han-soo
2019-11-11 18:02
라인
Genexine’s new immunotherapy shows stability even in high dose
by Jeong Sae-im
2019-11-11 13:36
Medpacto releases trial results at US conference
by Lee Han-soo
2019-11-11 13:27
Yuhan, Cyclica to co-develop new drugs
by Lee Han-soo
2019-11-07 18:01
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off
by Kim Yun-mi
2019-11-07 16:10
‘One-third of heart attack survivors overlook risk of recurrence’
by Lee Han-soo
2019-11-06 16:34
라인
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis
by Kim Yun-mi
2019-11-06 16:00
Crystal Genomics, Daehwa win patent for patch-form arthritis drug
by Lee Han-soo
2019-11-06 15:57
Dong-A ST's treatment of nail athlete's foot dominates local market
by Lee Han-soo
2019-11-06 14:09
Regulator to consider re-classifying choline alfoscerate as functional food
by Kim Yun-mi
2019-11-06 13:54
Daewoong to sell Merck's cardiovascular disease treatment
by Lee Han-soo
2019-11-05 15:05
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top